Sinco Pharmaceuticals Holdings Limited (06833.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 18Aug 21Aug 26Aug 31Sep 3Sep 8Sep 11Sep 18

Key dataSep 18, 2026

OpenHKD 0.12

From 52W high−46.00%

Volume344000.00

Market capHKD 274.44M

P/E (TTM)7.8x

P/S (TTM)0.1x

Div yield1.24%

Key dataSep 18, 2026

Open

HKD 0.12

From 52W high

−46.00%

Volume

344000.00

Market cap

HKD 274.44M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

P/E (TTM)

7.8x

RSI (14)

30.5

MomentumView details →

1D Return

−0.74%

YTD Return

−23.73%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

7.8x

EV/EBITDA

−0.2x

EV/Sales

−0.0x

P/S (TTM)

0.1x

P/B (TTM)

0.3x

ProfitabilityView details →

Gross Margin

11.12%

Net Margin

1.58%

EBITDA Margin

4.53%

ROE (TTM)

4.28%

ROA (TTM)

1.44%

Asset Turnover

0.97x

GrowthView details →

Revenue YoY

−22.81%

EPS YoY

−27.09%

FCF YoY

+6909.46%

Revenue CAGR 3Y

−2.82%

EPS CAGR 3Y

−20.78%

EBITDA YoY

−25.70%

MomentumView details →

1D Return

−0.74%

YTD Return

−23.73%

1Y Return

−42.55%

RSI (14)

30.5

vs 50D SMA

−16.99%

vs 200D SMA

−22.82%

Capital & dividendView details →

Debt/Equity

0.16x

Current Ratio

1.16x

Quick Ratio

0.92x

Div Yield

1.24%

Div Rate

HKD 0.00

Div Growth 1Y

−16.50%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

4.41B

Net Income (TTM)

72.96M

Op. CF (TTM)

335.31M

Latest newsMore news →

Xingkerong Medical reported interim results for the six months ended June 2026, with revenue of RMB 1.0325 billion, down 13.7% year-on-year, and net profit of RMB 19.91 million, down 18.4% year-on-year.23d ago

Similar companies

Powerwin Tech Group Limited02405.HK Qian Xun Technology Limited01640.HK Allegro Culture Ltd.00550.HK Xunlei LimitedXNET B.Duck Semk Holdings International Limited02250.HK Plus Group Holdings Inc.02486.HK Find similar companies →

Latest newsMore news →

Xingkerong Medical reported interim results for the six months ended June 2026, with revenue of RMB 1.0325 billion, down 13.7% year-on-year, and net profit of RMB 19.91 million, down 18.4% year-on-year.23d ago